Lung Injury Risk in Traumatic Brain Injury Managed With Optimal Cerebral Perfusion Pressure Guided-Therapy
, , , , e
08 mag 2023
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Research Article
Pubblicato online: 08 mag 2023
Pagine: 97 - 105
Ricevuto: 11 ago 2022
Accettato: 31 gen 2023
DOI: https://doi.org/10.2478/jccm-2023-0009
Parole chiave
© 2023 Celeste Dias et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Fig. 1.

Fig. 2.

Fig. 3.

Demographic, Monitoring, Management and Outcome data of patients with severe acute Traumatic Brain Injury_
Variables | Mean±sd /Median (IQR) | |
---|---|---|
Number of Patients | Total | 92 |
Multiple Trauma | 45 (49%) | |
Thoracic Trauma | 19 (21%) | |
Age (Years) | 53 ± 21 | |
Gender | Male | 79 (86%) |
Female | 13 (14%) | |
GCS at admission | 7 (IQR 5) | |
APACHE II | 19 ± 6 | |
Apache II mortality (%) | 33 ± 17 | |
CT Marshall Classification | 3 (IQR 2) | |
FiO2 | 0.5 ± 0.13 | |
PFratio | 305 ± 88 | |
PaO2(mmHg) | 146.5 ± 28.5 | |
PaCO2(mmHg) | 38.1 ± 3.7 | |
SaO2(%) | 98.6 ± 0.74 | |
RR (cycles/min) | 17 ± 4 | |
MV (L/min) | 9.45 ± 2.18 | |
PEEP (cmH20) | 6,2 ± 1,3 | |
Ppl (cmH20) | 19.7 ± 4.8 | |
DP=Ppl-PEEP (cmH20) | 15.9 ± 3.5 | |
Shunt fraction (Qs/Qt) (%) | 16.3±6.7 | |
Compliance | 43 ± 13.8 | |
Fluid Balance (ml/d) | 171 ± 564 | |
Therapy Intensity Level (TIL) | 2 (IQR 1) | |
HR (bpm) | 71.9 ± 10.5 | |
ABP (mmHg) | 96.7 ± 7.0 | |
ICP (mmHg) | 11.2 ± 5.8 | |
CPP(mmHg) | 85.9 ± 7.4 | |
PRx | 0.03 ± 0.19 | |
CPPopt (mmHg) | 88.7 ± 8.5 | |
CPP-CPPopt (mmHg) | −2.8 ± 10.2 | |
LOS ICU (days) | 22 ± 26 | |
LOS Hosp (days) | 48 ± 48 | |
Mortality | 14 (15.2%) | |
GOS at 3 months | 3 (IQR 2) |
Estimates from the final mixed-effects regression models for PFratio, CPP-CPPopt and Driving Pressure across time (10 days), adjusted for other variables of interest_
Variables | FIXED EFFECTS | RANDOM EFFECT | ||
---|---|---|---|---|
Coefficient | St Error | p-value | St deviation | |
Intercept | 436.42 | 17.63 | <0.001 | 59.25 |
Time (days) | −27.12 | 4.56 | <0.001 | |
Days2 | 2.175 | 0.48 | <0.001 | |
Female | 99.28 | 23.39 | <0.001 | |
PRx | −49.99 | 15.68 | 0.002 | |
Ppl-Peep | −5.34 | 0.97 | <0.001 | |
Intercept | −2.37 | 1.58 | 0.133 | 2.95 |
Dead | −0.79 | 1.72 | 0.647 | |
Time (days) | −0.56 | 0.28 | 0.048 | |
Time*Dead | 1.10 | 0.31 | <0.001 | |
Intercept | 14.76 | 1.10 | <0.001 | 2.85 |
Dead | −0.43 | 1.20 | 0.718 | |
Time (days) | 0.68 | 0.15 | <0.001 | |
Time*Dead | −0.34 | 0.17 | 0.041 |